25 XP   0   0   10

Precigen Inc
Buy, Hold or Sell?

Let's analyse Precigen together

PenkeI guess you are interested in Precigen Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Precigen Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Precigen Inc

I send you an email if I find something interesting about Precigen Inc.

Quick analysis of Precigen (30 sec.)










What can you expect buying and holding a share of Precigen? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€0.44
Expected worth in 1 year
€0.41
How sure are you?
38.9%

+ What do you gain per year?

Total Gains per Share
€-0.03
Return On Investment
-2.2%

For what price can you sell your share?

Current Price per Share
€1.29
Expected price per share
€1.09 - €1.67
How sure are you?
50%

1. Valuation of Precigen (5 min.)




Live pricePrice per Share (EOD)

€1.29

Intrinsic Value Per Share

€-1.67 - €-1.90

Total Value Per Share

€-1.23 - €-1.46

2. Growth of Precigen (5 min.)




Is Precigen growing?

Current yearPrevious yearGrowGrow %
How rich?$118.5m$99.5m$54.5m35.4%

How much money is Precigen making?

Current yearPrevious yearGrowGrow %
Making money-$23.9m$7m-$31m-129.5%
Net Profit Margin-1,626.4%-350.3%--

How much money comes from the company's main activities?

3. Financial Health of Precigen (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#369 / 1031

Most Revenue
#341 / 1031

Most Profit
#114 / 1031

Most Efficient
#830 / 1031

What can you expect buying and holding a share of Precigen? (5 min.)

Welcome investor! Precigen's management wants to use your money to grow the business. In return you get a share of Precigen.

What can you expect buying and holding a share of Precigen?

First you should know what it really means to hold a share of Precigen. And how you can make/lose money.

Speculation

The Price per Share of Precigen is €1.29. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Precigen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Precigen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €0.44. Based on the TTM, the Book Value Change Per Share is €-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is €0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Precigen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.13-10.3%-0.09-7.2%0.032.2%-0.12-9.5%-0.12-9.5%
Usd Book Value Change Per Share-0.10-7.7%-0.01-0.6%0.021.5%0.032.1%0.032.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.10-7.7%-0.01-0.6%0.021.5%0.032.1%0.032.1%
Usd Price Per Share1.36-1.23-1.79-3.51-3.51-
Price to Earnings Ratio-2.57--3.46--3.45--6.99--6.99-
Price-to-Total Gains Ratio-13.64--10.83--12.21-6.04-6.04-
Price to Book Ratio2.86-2.11-4.97-9.28-9.28-
Price-to-Total Gains Ratio-13.64--10.83--12.21-6.04-6.04-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.395393
Number of shares716
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.03
Usd Total Gains Per Share-0.010.03
Gains per Quarter (716 shares)-5.5818.94
Gains per Year (716 shares)-22.3275.75
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-22-3207666
20-45-540151142
30-67-760227218
40-89-980303294
50-112-1200379370
60-134-1420454446
70-156-1640530522
80-179-1860606598
90-201-2080682674
100-223-2300757750

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.017.00.05.6%1.017.00.05.6%1.017.00.05.6%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%7.011.00.038.9%7.011.00.038.9%7.011.00.038.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.018.00.0%0.00.018.00.0%0.00.018.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%7.011.00.038.9%7.011.00.038.9%7.011.00.038.9%

Fundamentals of Precigen

About Precigen Inc

Precigen, Inc. operates as a discovery and clinical-stage biopharmaceutical company that develops gene and cell therapies using precision technology to target diseases in therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. It operates through two segments, Biopharmaceuticals and Exemplar. The company offers therapeutic platforms consisting of UltraCAR-T to provide chimeric antigen receptor T cell therapies for cancer patients; AdenoVerse immunotherapy, which utilizes a library of proprietary adenovectors for gene delivery of therapeutic effectors, immunomodulators, and vaccine antigen; and ActoBiotics for specific disease modification. It also develops programs based on the UltraCAR-T platform, including PRGN-3005 in Phase 1b clinical trial to treat advanced ovarian, fallopian tube, or primary peritoneal cancer; PRGN-3006 in Phase 1b trial for patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndromes; and PRGN-3007 in Phase 1/1b trial for the treatment of advanced receptor tyrosine kinase-like orphan receptor 1-positive, hematologic, and solid tumors. In addition, the company is developing programs based on the AdenoVerse immunotherapy platform comprising PRGN-2009 in Phase 2 trial for patients with HPV-associated cancer; and PRGN-2012 in Phase ½ trial to treat recurrent respiratory papillomatosis, as well as AG019, which is based on the ActoBiotics platform and in Phase 1b/2a trial, to treat type 1 diabetes mellitus. Further, it provides UltraPorator, a proprietary electroporation device; and develops research models and services for healthcare research applications. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in February 2020. Precigen, Inc. was founded in 1998 and is headquartered in Germantown, Maryland.

Fundamental data was last updated by Penke on 2024-03-27 17:56:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Precigen Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Precigen earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Precigen to the Biotechnology industry mean.
  • A Net Profit Margin of -2,691.9% means that €-26.92 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Precigen Inc:

  • The MRQ is -2,691.9%. The company is making a huge loss. -2
  • The TTM is -1,626.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-2,691.9%TTM-1,626.4%-1,065.5%
TTM-1,626.4%YOY-350.3%-1,276.0%
TTM-1,626.4%5Y-622.6%-1,003.8%
5Y-622.6%10Y-622.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2,691.9%-171.8%-2,520.1%
TTM-1,626.4%-205.8%-1,420.6%
YOY-350.3%-262.1%-88.2%
5Y-622.6%-455.6%-167.0%
10Y-622.6%-589.0%-33.6%
1.1.2. Return on Assets

Shows how efficient Precigen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Precigen to the Biotechnology industry mean.
  • -21.9% Return on Assets means that Precigen generated €-0.22 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Precigen Inc:

  • The MRQ is -21.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -12.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-21.9%TTM-12.9%-9.0%
TTM-12.9%YOY3.1%-15.9%
TTM-12.9%5Y-8.7%-4.1%
5Y-8.7%10Y-8.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-21.9%-12.5%-9.4%
TTM-12.9%-12.2%-0.7%
YOY3.1%-11.2%+14.3%
5Y-8.7%-13.4%+4.7%
10Y-8.7%-14.7%+6.0%
1.1.3. Return on Equity

Shows how efficient Precigen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Precigen to the Biotechnology industry mean.
  • -27.9% Return on Equity means Precigen generated €-0.28 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Precigen Inc:

  • The MRQ is -27.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -16.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-27.9%TTM-16.5%-11.4%
TTM-16.5%YOY-3.5%-13.0%
TTM-16.5%5Y-37.3%+20.9%
5Y-37.3%10Y-37.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-27.9%-15.8%-12.1%
TTM-16.5%-15.7%-0.8%
YOY-3.5%-13.9%+10.4%
5Y-37.3%-18.3%-19.0%
10Y-37.3%-19.2%-18.1%

1.2. Operating Efficiency of Precigen Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Precigen is operating .

  • Measures how much profit Precigen makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Precigen to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Precigen Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-298.8%+298.8%
TTM-298.8%YOY-539.4%+240.6%
TTM-298.8%5Y-260.6%-38.2%
5Y-260.6%10Y-260.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.1%+299.1%
TTM-298.8%-210.1%-88.7%
YOY-539.4%-279.7%-259.7%
5Y-260.6%-459.9%+199.3%
10Y-260.6%-596.9%+336.3%
1.2.2. Operating Ratio

Measures how efficient Precigen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 21.15 means that the operating costs are €21.15 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Precigen Inc:

  • The MRQ is 21.152. The company is inefficient in keeping operating costs low. -1
  • The TTM is 16.718. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ21.152TTM16.718+4.434
TTM16.718YOY6.852+9.866
TTM16.7185Y6.850+9.868
5Y6.85010Y6.8500.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ21.1522.861+18.291
TTM16.7183.193+13.525
YOY6.8523.615+3.237
5Y6.8505.560+1.290
10Y6.8507.396-0.546

1.3. Liquidity of Precigen Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Precigen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.99 means the company has €2.99 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Precigen Inc:

  • The MRQ is 2.991. The company is able to pay all its short-term debts. +1
  • The TTM is 3.050. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.991TTM3.050-0.059
TTM3.050YOY3.653-0.603
TTM3.0505Y3.635-0.585
5Y3.63510Y3.6350.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9913.986-0.995
TTM3.0504.440-1.390
YOY3.6535.552-1.899
5Y3.6356.158-2.523
10Y3.6356.492-2.857
1.3.2. Quick Ratio

Measures if Precigen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Precigen to the Biotechnology industry mean.
  • A Quick Ratio of 2.44 means the company can pay off €2.44 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Precigen Inc:

  • The MRQ is 2.444. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.318. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.444TTM2.318+0.126
TTM2.318YOY1.918+0.400
TTM2.3185Y2.244+0.074
5Y2.24410Y2.2440.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4443.638-1.194
TTM2.3184.168-1.850
YOY1.9185.515-3.597
5Y2.2446.012-3.768
10Y2.2446.209-3.965

1.4. Solvency of Precigen Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Precigen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Precigen to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.22 means that Precigen assets are financed with 21.5% credit (debt) and the remaining percentage (100% - 21.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Precigen Inc:

  • The MRQ is 0.215. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.219. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.215TTM0.219-0.004
TTM0.219YOY0.618-0.399
TTM0.2195Y0.589-0.370
5Y0.58910Y0.5890.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2150.335-0.120
TTM0.2190.330-0.111
YOY0.6180.267+0.351
5Y0.5890.367+0.222
10Y0.5890.378+0.211
1.4.2. Debt to Equity Ratio

Measures if Precigen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Precigen to the Biotechnology industry mean.
  • A Debt to Equity ratio of 27.5% means that company has €0.27 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Precigen Inc:

  • The MRQ is 0.275. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.282. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.275TTM0.282-0.007
TTM0.282YOY2.462-2.180
TTM0.2825Y2.412-2.131
5Y2.41210Y2.4120.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2750.376-0.101
TTM0.2820.398-0.116
YOY2.4620.334+2.128
5Y2.4120.429+1.983
10Y2.4120.476+1.936

2. Market Valuation of Precigen Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Precigen generates.

  • Above 15 is considered overpriced but always compare Precigen to the Biotechnology industry mean.
  • A PE ratio of -2.57 means the investor is paying €-2.57 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Precigen Inc:

  • The EOD is -2.627. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.566. Based on the earnings, the company is expensive. -2
  • The TTM is -3.462. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.627MRQ-2.566-0.061
MRQ-2.566TTM-3.462+0.896
TTM-3.462YOY-3.445-0.017
TTM-3.4625Y-6.987+3.525
5Y-6.98710Y-6.9870.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.627-2.643+0.016
MRQ-2.566-2.418-0.148
TTM-3.462-2.742-0.720
YOY-3.445-4.123+0.678
5Y-6.987-6.257-0.730
10Y-6.987-6.478-0.509
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Precigen Inc:

  • The EOD is -5.165. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -5.045. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.565. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.165MRQ-5.045-0.120
MRQ-5.045TTM-4.565-0.480
TTM-4.565YOY-6.837+2.272
TTM-4.5655Y-11.225+6.660
5Y-11.22510Y-11.2250.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.165-3.244-1.921
MRQ-5.045-2.939-2.106
TTM-4.565-3.478-1.087
YOY-6.837-5.592-1.245
5Y-11.225-8.473-2.752
10Y-11.225-8.881-2.344
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Precigen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.86 means the investor is paying €2.86 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Precigen Inc:

  • The EOD is 2.931. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.863. Based on the equity, the company is underpriced. +1
  • The TTM is 2.112. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.931MRQ2.863+0.068
MRQ2.863TTM2.112+0.751
TTM2.112YOY4.975-2.863
TTM2.1125Y9.281-7.169
5Y9.28110Y9.2810.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.9312.124+0.807
MRQ2.8632.041+0.822
TTM2.1122.118-0.006
YOY4.9752.915+2.060
5Y9.2813.682+5.599
10Y9.2814.114+5.167
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Precigen Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.092-0.007-92%0.018-626%0.024-478%0.024-478%
Book Value Per Share--0.4400.560-21%0.370+19%0.4410%0.4410%
Current Ratio--2.9913.050-2%3.653-18%3.635-18%3.635-18%
Debt To Asset Ratio--0.2150.219-2%0.618-65%0.589-63%0.589-63%
Debt To Equity Ratio--0.2750.282-2%2.462-89%2.412-89%2.412-89%
Dividend Per Share----0%-0%-0%-0%
Eps---0.123-0.085-31%0.026-567%-0.113-8%-0.113-8%
Free Cash Flow Per Share---0.062-0.0620%-0.065+4%-0.066+6%-0.066+6%
Free Cash Flow To Equity Per Share---0.062-0.089+42%-0.138+121%-0.055-12%-0.055-12%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---1.902--------
Intrinsic Value_10Y_min---1.669--------
Intrinsic Value_1Y_max---0.240--------
Intrinsic Value_1Y_min---0.236--------
Intrinsic Value_3Y_max---0.683--------
Intrinsic Value_3Y_min---0.653--------
Intrinsic Value_5Y_max---1.081--------
Intrinsic Value_5Y_min---1.006--------
Market Cap321105520.320+2%313638060.960288022834.360+9%411805383.860-24%809482931.178-61%809482931.178-61%
Net Profit Margin---26.919-16.264-40%-3.503-87%-6.226-77%-6.226-77%
Operating Margin----2.9880%-5.3940%-2.6060%-2.6060%
Operating Ratio--21.15216.718+27%6.852+209%6.850+209%6.850+209%
Pb Ratio2.931+2%2.8632.112+36%4.975-42%9.281-69%9.281-69%
Pe Ratio-2.627-2%-2.566-3.462+35%-3.445+34%-6.987+172%-6.987+172%
Price Per Share1.290+2%1.2601.134+11%1.654-24%3.247-61%3.247-61%
Price To Free Cash Flow Ratio-5.165-2%-5.045-4.565-10%-6.837+36%-11.225+122%-11.225+122%
Price To Total Gains Ratio-13.965-2%-13.640-10.830-21%-12.208-10%6.042-326%6.042-326%
Quick Ratio--2.4442.318+5%1.918+27%2.244+9%2.244+9%
Return On Assets---0.219-0.129-41%0.031-817%-0.087-60%-0.087-60%
Return On Equity---0.279-0.165-41%-0.035-87%-0.373+34%-0.373+34%
Total Gains Per Share---0.092-0.007-92%0.018-626%0.024-478%0.024-478%
Usd Book Value--118501750.462154134628.207-23%99573151.391+19%119449002.664-1%119449002.664-1%
Usd Book Value Change Per Share---0.100-0.008-92%0.019-626%0.026-478%0.026-478%
Usd Book Value Per Share--0.4760.606-21%0.400+19%0.4770%0.4770%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.133-0.092-31%0.028-567%-0.123-8%-0.123-8%
Usd Free Cash Flow---16811532.068-17117041.737+2%-17492803.630+4%-15889447.330-5%-15889447.330-5%
Usd Free Cash Flow Per Share---0.068-0.0670%-0.070+4%-0.071+6%-0.071+6%
Usd Free Cash Flow To Equity Per Share---0.068-0.096+42%-0.149+121%-0.060-12%-0.060-12%
Usd Market Cap347339841.330+2%339262290.540311554299.927+9%445449883.721-24%875617686.655-61%875617686.655-61%
Usd Price Per Share1.395+2%1.3631.227+11%1.790-24%3.512-61%3.512-61%
Usd Profit---33057046.222-23976758.840-27%7079474.058-567%-30730028.130-7%-30730028.130-7%
Usd Revenue--1228038.8661556299.255-21%13354672.662-91%16561301.926-93%16561301.926-93%
Usd Total Gains Per Share---0.100-0.008-92%0.019-626%0.026-478%0.026-478%
 EOD+5 -3MRQTTM+10 -22YOY+13 -195Y+8 -2410Y+8 -24

3.2. Fundamental Score

Let's check the fundamental score of Precigen Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.627
Price to Book Ratio (EOD)Between0-12.931
Net Profit Margin (MRQ)Greater than0-26.919
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.444
Current Ratio (MRQ)Greater than12.991
Debt to Asset Ratio (MRQ)Less than10.215
Debt to Equity Ratio (MRQ)Less than10.275
Return on Equity (MRQ)Greater than0.15-0.279
Return on Assets (MRQ)Greater than0.05-0.219
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Precigen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.879
Ma 20Greater thanMa 501.392
Ma 50Greater thanMa 1001.334
Ma 100Greater thanMa 2001.220
OpenGreater thanClose1.290
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Total Other Income Expense Net 244107351-31141219260-10,349-10,089



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets151,043
Total Liabilities32,545
Total Stockholder Equity118,498
 As reported
Total Liabilities 32,545
Total Stockholder Equity+ 118,498
Total Assets = 151,043

Assets

Total Assets151,043
Total Current Assets68,755
Long-term Assets82,288
Total Current Assets
Cash And Cash Equivalents 7,578
Short-term Investments 55,277
Net Receivables 902
Other Current Assets 4,325
Total Current Assets  (as reported)68,755
Total Current Assets  (calculated)68,082
+/- 673
Long-term Assets
Property Plant Equipment 14,129
Goodwill 26,612
Intangible Assets 40,701
Long-term Assets Other 846
Long-term Assets  (as reported)82,288
Long-term Assets  (calculated)82,288
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities22,985
Long-term Liabilities9,560
Total Stockholder Equity118,498
Total Current Liabilities
Accounts payable 1,726
Total Current Liabilities  (as reported)22,985
Total Current Liabilities  (calculated)1,726
+/- 21,259
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt7,097
Long-term Liabilities  (as reported)9,560
Long-term Liabilities  (calculated)7,097
+/- 2,463
Total Stockholder Equity
Total Stockholder Equity (as reported)118,498
Total Stockholder Equity (calculated)0
+/- 118,498
Other
Common Stock Shares Outstanding 248,919
Net Invested Capital 118,498
Net Working Capital 45,770
Property Plant and Equipment Gross 38,412



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
604,905
455,763
404,672
361,715
336,186
314,587
406,984
402,573
376,899
359,856
335,568
321,224
259,245
215,977
241,546
207,527
190,688
151,043
151,043190,688207,527241,546215,977259,245321,224335,568359,856376,899402,573406,984314,587336,186361,715404,672455,763604,905
   > Total Current Assets 
157,332
234,643
189,383
172,995
151,116
148,948
144,118
156,685
153,092
156,628
154,937
164,619
162,806
118,159
137,743
105,632
92,988
68,755
68,75592,988105,632137,743118,159162,806164,619154,937156,628153,092156,685144,118148,948151,116172,995189,383234,643157,332
       Cash And Cash Equivalents 
44,428
65,793
37,840
46,713
27,740
51,792
27,355
36,412
41,728
42,920
40,321
43,844
9,067
4,858
9,740
16,546
10,076
7,578
7,57810,07616,5469,7404,8589,06743,84440,32142,92041,72836,41227,35551,79227,74046,71337,84065,79344,428
       Short-term Investments 
61,605
9,260
111,332
86,292
85,358
48,325
78,331
78,694
72,684
72,240
71,821
71,453
62,260
51,092
94,351
71,888
63,679
55,277
55,27763,67971,88894,35151,09262,26071,45371,82172,24072,68478,69478,33148,32585,35886,292111,3329,26061,605
       Net Receivables 
20,413
26,228
19,979
23,995
19,360
20,427
21,357
26,671
21,083
21,471
24,866
1,871
2,454
13,804
1,771
14,406
988
902
90298814,4061,77113,8042,4541,87124,86621,47121,08326,67121,35720,42719,36023,99519,97926,22820,413
       Inventory 
17,295
16,097
14,636
12,729
10,348
11,359
10,637
11,413
9,936
13,261
12,730
224
219
287
0
0
0
0
000028721922412,73013,2619,93611,41310,63711,35910,34812,72914,63616,09717,295
   > Long-term Assets 
447,573
221,120
215,289
188,720
185,070
165,639
262,866
245,888
223,807
203,228
180,631
156,605
96,439
97,818
103,803
101,895
97,700
82,288
82,28897,700101,895103,80397,81896,439156,605180,631203,228223,807245,888262,866165,639185,070188,720215,289221,120447,573
       Property Plant Equipment 
165,917
86,197
83,663
67,639
63,981
44,277
42,355
45,072
44,522
45,215
44,546
16,670
16,322
15,292
14,397
14,059
14,179
14,129
14,12914,17914,05914,39715,29216,32216,67044,54645,21544,52245,07242,35544,27763,98167,63983,66386,197165,917
       Goodwill 
147,949
63,754
63,703
54,122
54,237
54,363
54,238
54,273
54,206
54,148
53,613
36,864
36,713
36,923
36,966
36,966
36,894
26,612
26,61236,89436,96636,96636,92336,71336,86453,61354,14854,20654,27354,23854,36354,23754,12263,70363,754147,949
       Long Term Investments 
24,002
1,461
1,108
859
337
0
103,610
85,269
66,926
48,562
29,914
11,877
0
0
7,460
7,127
5,271
0
05,2717,1277,4600011,87729,91448,56266,92685,269103,61003378591,1081,46124,002
       Intangible Assets 
107,141
68,346
65,489
64,759
65,018
65,396
61,230
59,942
56,914
54,115
51,427
45,933
42,416
44,455
43,848
42,656
40,426
40,701
40,70140,42642,65643,84844,45542,41645,93351,42754,11556,91459,94261,23065,39665,01864,75965,48968,346107,141
       Other Assets 
1,921
1,362
1,326
1,341
1,497
1,603
1,433
1,332
1,239
1,188
1,131
45,261
871
1,025
0
949
0
0
0094901,02587145,2611,1311,1881,2391,3321,4331,6031,4971,3411,3261,3621,921
> Total Liabilities 
376,484
384,052
317,443
312,173
277,634
247,413
232,189
243,377
245,652
252,508
261,732
265,571
116,713
89,718
57,413
41,317
43,010
32,545
32,54543,01041,31757,41389,718116,713265,571261,732252,508245,652243,377232,189247,413277,634312,173317,443384,052376,484
   > Total Current Liabilities 
81,955
122,912
70,637
64,100
30,661
42,127
25,243
28,869
28,989
34,645
25,601
29,901
104,864
78,645
46,733
30,773
32,875
22,985
22,98532,87530,77346,73378,645104,86429,90125,60134,64528,98928,86925,24342,12730,66164,10070,637122,91281,955
       Short Long Term Debt 
32,002
33,592
33,091
32,108
421
360
359
356
355
402
355
0
82,069
43,219
13,819
0
0
0
00013,81943,21982,069035540235535635936042132,10833,09133,59232,002
       Accounts payable 
7,395
5,917
4,777
3,650
4,233
4,598
4,295
4,937
3,624
5,405
4,415
2,668
4,201
4,068
3,809
2,510
2,351
1,726
1,7262,3512,5103,8094,0684,2012,6684,4155,4053,6244,9374,2954,5984,2333,6504,7775,9177,395
       Other Current Liabilities 
13,588
53,939
12,135
7,624
5,359
17,726
4,932
4,263
4,579
5,332
3,559
12,534
76
25
0
18,765
0
0
0018,7650257612,5343,5595,3324,5794,2634,93217,7265,3597,62412,13553,93913,588
   > Long-term Liabilities 
294,529
261,140
246,806
248,073
246,973
205,286
206,946
214,508
216,663
217,863
236,131
235,670
11,849
11,073
10,680
10,544
10,135
9,560
9,56010,13510,54410,68011,07311,849235,670236,131217,863216,663214,508206,946205,286246,973248,073246,806261,140294,529
       Long term Debt 
184,034
186,321
188,730
191,205
193,801
171,522
174,158
176,922
179,817
182,749
201,112
198,674
0
0
0
0
0
0
000000198,674201,112182,749179,817176,922174,158171,522193,801191,205188,730186,321184,034
       Capital Lease Obligations Min Short Term Debt
44,406
28,031
26,722
25,726
24,907
10,401
9,601
13,758
13,158
11,053
11,098
9,131
8,980
8,201
7,867
7,966
7,392
7,097
7,0977,3927,9667,8678,2018,9809,13111,09811,05313,15813,7589,60110,40124,90725,72626,72228,03144,406
       Other Liabilities 
72,313
50,970
35,662
35,656
32,849
26,020
25,845
25,765
25,647
25,612
25,511
28,898
3,910
4,081
0
3,999
0
0
003,99904,0813,91028,89825,51125,61225,64725,76525,84526,02032,84935,65635,66250,97072,313
       Long-term Liabilities Other 
221
0
0
100
100
100
100
50
50
50
50
0
0
0
0
0
0
0
00000005050505010010010010000221
> Total Stockholder Equity
228,421
71,711
87,229
49,542
58,552
67,174
174,795
159,196
131,247
107,348
73,836
55,653
142,532
126,259
184,133
166,210
147,678
118,498
118,498147,678166,210184,133126,259142,53255,65373,836107,348131,247159,196174,79567,17458,55249,54287,22971,711228,421
   Common Stock000000000000000000
   Retained Earnings Total Equity000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000
   Capital Surplus 000000000000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
-33,102
-27,468
-1,354
-650
1,362
3,997
1,746
2,541
1,515
203
-1,699
-4,556
-7,181
-3,488
0
-2,518
0
0
00-2,5180-3,488-7,181-4,556-1,6992031,5152,5411,7463,9971,362-650-1,354-27,468-33,102



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue6,225
Cost of Revenue-6,119
Gross Profit106106
 
Operating Income (+$)
Gross Profit106
Operating Expense-95,148
Operating Income-88,923-95,042
 
Operating Expense (+$)
Research Development48,614
Selling General Administrative40,415
Selling And Marketing Expenses-
Operating Expense95,14889,029
 
Net Interest Income (+$)
Interest Income3,237
Interest Expense-468
Other Finance Cost-0
Net Interest Income2,769
 
Pretax Income (+$)
Operating Income-88,923
Net Interest Income2,769
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-96,362-78,715
EBIT - interestExpense = -468
-95,904
-95,436
Interest Expense468
Earnings Before Interest and Taxes (EBIT)--95,894
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-96,362
Tax Provision--458
Net Income From Continuing Ops-95,904-95,904
Net Income-95,904
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-10,208-2,769
 

Technical Analysis of Precigen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Precigen. The general trend of Precigen is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Precigen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Precigen Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.6 < 1.67 < 1.67.

The bearish price targets are: 1.27 > 1.21 > 1.09.

Tweet this
Precigen Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Precigen Inc. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Precigen Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Precigen Inc. The current macd is -0.015863.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Precigen price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Precigen. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Precigen price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Precigen Inc Daily Moving Average Convergence/Divergence (MACD) ChartPrecigen Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Precigen Inc. The current adx is 19.16.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Precigen shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Precigen Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Precigen Inc. The current sar is 1.41640936.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Precigen Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Precigen Inc. The current rsi is 44.88. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Precigen Inc Daily Relative Strength Index (RSI) ChartPrecigen Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Precigen Inc. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Precigen price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Precigen Inc Daily Stochastic Oscillator ChartPrecigen Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Precigen Inc. The current cci is -79.17498337.

Precigen Inc Daily Commodity Channel Index (CCI) ChartPrecigen Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Precigen Inc. The current cmo is -15.03149002.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Precigen Inc Daily Chande Momentum Oscillator (CMO) ChartPrecigen Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Precigen Inc. The current willr is -93.93939394.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Precigen Inc Daily Williams %R ChartPrecigen Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Precigen Inc.

Precigen Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Precigen Inc. The current atr is 0.05353845.

Precigen Inc Daily Average True Range (ATR) ChartPrecigen Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Precigen Inc. The current obv is 143,816.

Precigen Inc Daily On-Balance Volume (OBV) ChartPrecigen Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Precigen Inc. The current mfi is 38.75.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Precigen Inc Daily Money Flow Index (MFI) ChartPrecigen Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Precigen Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-07 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-08 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-09 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-10 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-13 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-14 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-15 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-17 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-20 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-21 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-22 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-23 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-24 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-27 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-29 00:00:00MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-30 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-06 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-11 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-13 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-14 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-21 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-27 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-12 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-15 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-16 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-25 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-26 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-19 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-27 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-28 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-01 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-05 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-06 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-08 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-12 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-13 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-20 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-25 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-26 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.

6.3. Candlestick Patterns

Precigen Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Precigen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.879
Ma 20Greater thanMa 501.392
Ma 50Greater thanMa 1001.334
Ma 100Greater thanMa 2001.220
OpenGreater thanClose1.290
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Precigen with someone you think should read this too:
  • Are you bullish or bearish on Precigen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Precigen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Precigen Inc

I send you an email if I find something interesting about Precigen Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Precigen Inc.

Receive notifications about Precigen Inc in your mailbox!